|
Nobuaki Ochi
Department Kawasaki Medical School Kawasaki Medical School, Department of General Internal Medicine 4, Position Assistant Professor |
|
| Article types | 総説 |
| Language | English |
| Peer review | Peer reviewed |
| Presence of invitation | Invited paper |
| Title | What can we learn from 3 phase III trials of ASCEND-4: ceritinib vs. platinum/pemetrexed with pemetrexed maintenance, PROFILE 1004: crizotinib vs. platinum/pemetrexed, and J-ALEX: alectinib vs. crizotinib? |
| Journal | Formal name：Translational Cancer Research Abbreviation：Transl Cancer Res |
| Domestic / Foregin | Foregin |
| Volume, Issue, Page | 6,pp.S515-S518 |
| Author and coauthor | Ochi Nobuaki, Takigawa Nagio |
| Authorship | Lead author |
| Publication date | 2017/04 |